Can extra chemo keep aggressive cancer at bay?

This study tested whether continuing chemotherapy with the drug gemcitabine after initial treatment could help patients with advanced pleural mesothelioma keep their cancer from worsening longer. The trial involved 64 patients whose cancer had stabilized or responded to first-line chemotherapy, randomly assigning them to receive either gemcitabine plus supportive care or supportive care alone. Researchers measured how long patients lived without their cancer progressing and monitored treatment side effects.